Production (Stage)
Trinity Biotech plc
TRIB
$0.6341
-$0.0374-5.57%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 56.83M | 59.13M | 69.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 56.83M | 59.13M | 69.37M |
| Cost of Revenue | -- | -- | 37.38M | 38.87M | 49.29M |
| Gross Profit | -- | -- | 19.45M | 20.26M | 20.08M |
| SG&A Expenses | -- | -- | 31.15M | 33.89M | 23.42M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -141.00K | -482.00K | 2.94M |
| Total Operating Expenses | -- | -- | 72.77M | 76.71M | 79.57M |
| Operating Income | -- | -- | -15.94M | -17.58M | -10.21M |
| Income Before Tax | -- | -- | -36.93M | -41.85M | -35.37M |
| Income Tax Expenses | -- | -- | -59.00K | -69.00K | -1.37M |
| Earnings from Continuing Operations | -- | -- | -36.87 | -41.78 | -34.00 |
| Earnings from Discontinued Operations | -- | -- | 12.85M | 13.19M | 1.81M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -24.02M | -28.60M | -32.20M |
| EBIT | -- | -- | -15.94M | -17.58M | -10.21M |
| EBITDA | -- | -- | -14.17M | -15.63M | -9.26M |
| EPS Basic | -- | -- | -62.75 | -74.09 | -108.08 |
| Normalized Basic EPS | -- | -- | -0.56 | -0.56 | -0.53 |
| EPS Diluted | -- | -- | -62.75 | -73.96 | -108.06 |
| Normalized Diluted EPS | -- | -- | -0.56 | -0.56 | -0.53 |
| Average Basic Shares Outstanding | -- | -- | 30.61M | 29.70M | 23.51M |
| Average Diluted Shares Outstanding | -- | -- | 1.53M | 1.48M | 1.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |